This antibody portfolio includes a wide range of tissue- & tumor-specific primary antibodies for basic research, product development and analysis of a variety of biological questions. The monoclonal antibodies are perfectly applicable for all cell or tissue biology studies and for the analysis of predictive markers in research.
p16 (CDKN2A, p16Ink4A), is key regulator of the cell cycle and involved in cell cycle control and cellular senescence. It is a specific inhibitor for Cdk4 and Cdk6 and binds to the phosphorylated Cdk-cyclin complex. A disruption of this pathway is commonly observed in cancer. p16 is lost in the majority of tumor cell lines and in most primary tumors. It is not expressed in melanoma. In carcinoma driven by an HPV (human papilloma virus) infection, p16 is often overexpressed.
The antibody is especially useful for immunoprecipitation. The epitope was localized within the 15 aa residues of the C-terminus of p16 protein.
Host: mouse
Antibody type: monoclonal
Isotype: IgG1
Clone: DCS-50
Immunogen: recombinant human p16 protein
UniprotID: Q9UH64 (human)
Synonym: putative protein CDKN2A-DT, CDKN2A antisense RNA 1, CDKN2A antisense gene protein 1, protein CDKN2A-AS1, susceptibility protein NSG-x, CDKN2A-DT, C9orf53, CDKN2A-AS1
Conjugate: unconjugated
Purification: affinity chromatography
Intended use: research use only
Application: ICC/IF, IHC, WB
Reactivity: human
Immunocytochemistry (ICC): assay dependent
Immunohistochemistry (IHC) - paraffin: 1:20-1:100 (1-5 μg/ml; microwave treatment recommended)
Western Blot (WB). 1:100-1:400 (0.25-1 μg/ml)